Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chicago Atlantic BDC, Inc.LIEN · Entity 6189 | 10% owner | August 17, 2026 | August 20, 2026 |
| Chicago Atlantic Real Estate Finance, Inc.REFI · Entity 6035 | Director · Executive Chairman | August 26, 2026 | August 28, 2026 |
| Vireo Growth Inc.VREOF · Entity 5397 | Director · Chief Executive Officer | November 13, 2025 | December 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chicago Atlantic BDC, Inc.
Report date August 17, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,000 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Purchase · Acquired 60,000 · Balance 60,000 F1: The price reported reflects the weighted-average purchase price from several discrete transactions executed throughout the Transaction Date at prices that ranged from $9.39 to $9.44 per share. Upon request, the Reporting Person has agreed to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectChicago Atlantic BDC Advisers, LLC | 2,887,204 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,887,204 F2: John Mazarakis, directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares of Common Stock owned by Chicago Atlantic BDC Advisers, LLC. Mr. Mazarakis disclaims beneficial ownership of the shares of Common Stock owned by Chicago Atlantic BDC Advisers, LLC except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectCA Credit SPV, LLC | 241,204 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 241,204 F3: John Mazarakis, directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares of Common Stock owned by CA Credit SPV, LLC. Mr. Mazarakis disclaims beneficial ownership of the shares of Common Stock owned by CA Credit SPV, LLC except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported reflects the weighted-average purchase price from several discrete transactions executed throughout the Transaction Date at prices that ranged from $9.39 to $9.44 per share. Upon request, the Reporting Person has agreed to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each price within the range set forth in this footnote.
F2: John Mazarakis, directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares of Common Stock owned by Chicago Atlantic BDC Advisers, LLC. Mr. Mazarakis disclaims beneficial ownership of the shares of Common Stock owned by Chicago Atlantic BDC Advisers, LLC except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3: John Mazarakis, directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares of Common Stock owned by CA Credit SPV, LLC. Mr. Mazarakis disclaims beneficial ownership of the shares of Common Stock owned by CA Credit SPV, LLC except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Chicago Atlantic Real Estate Finance, Inc.
Report date August 26, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 526,562 |
Ending reported balance
After 2026-08-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-26 · Purchase · Acquired 40,181 · Balance 519,032 F1: The price reported reflects the weighted-average purchase price from several discrete transactions executed throughout the Transaction Date at prices that ranged from $10.65 to $10.67 per share. Upon request, the Reporting Person has agreed to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each price within the range set forth in this footnote. Row 2 · 2026-08-27 · Purchase · Acquired 7,530 · Balance 526,562 |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 5,000 |
Reported balance
Holding disclosure · report date 2026-08-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,000 F2: The reporting person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectHeld through ownership of interests in Joppa Seasoning, LLC | 31,524 |
Reported balance
Holding disclosure · report date 2026-08-26 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 31,524 F2: The reporting person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported reflects the weighted-average purchase price from several discrete transactions executed throughout the Transaction Date at prices that ranged from $10.65 to $10.67 per share. Upon request, the Reporting Person has agreed to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each price within the range set forth in this footnote.
F2: The reporting person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
Vireo Growth Inc.
Report date November 13, 2025 · Filed December 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Subordinate Voting SharesSEC Table I · non-derivative | Direct | 9,833,737 |
Ending reported balance
After 2025-12-29 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2025-11-13 · Grant · Acquired 2,037,736 · Balance 5,237,736 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately. Row 2 · 2025-12-17 · Grant · Acquired 5,700,000 · Balance 10,937,736 F2: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 5,700,000 RSUs on December 17, 2025; 6,650,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date). Row 3 · 2025-12-17 · Grant · Acquired 3,200,000 · Balance 14,137,736 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately. Row 4 · 2025-12-29 · Tax withholding · Disposed 801,849 · Balance 13,335,887 F3: Certain RSUs held by the reporting person vested on November 13, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 801,849 subordinate voting shares were withheld for tax purposes. Row 5 · 2025-12-29 · Tax withholding · Disposed 3,502,150 · Balance 9,833,737 F4: Certain RSUs held by the reporting person vested on December 17, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 3,502,150 subordinate voting shares were withheld for tax purposes. |
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 13,300,000 |
Reported balance
After 2025-12-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-12-17 · Exercise / conversion · Disposed 5,700,000 · Balance 13,300,000 F2: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 5,700,000 RSUs on December 17, 2025; 6,650,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date). |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately.
F2: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 5,700,000 RSUs on December 17, 2025; 6,650,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date).
F3: Certain RSUs held by the reporting person vested on November 13, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 801,849 subordinate voting shares were withheld for tax purposes.
F4: Certain RSUs held by the reporting person vested on December 17, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 3,502,150 subordinate voting shares were withheld for tax purposes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2026 Filed Aug 28, 2026 15:24 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 7,530 | $10.67 | $80,345.10 |
DisclosureSEC source: 0001193125-26-374170 · ownership.xml · nonDerivative · entry 2 Mazarakis John · CIK 0001867660 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,562 Read SEC document |
| August 26, 2026 Filed Aug 28, 2026 15:24 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 40,181 | $10.67 | $428,594.65 |
DisclosureSEC source: 0001193125-26-374170 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 519,032 F1 · price: The price reported reflects the weighted-average purchase price from several discrete transactions executed throughout the Transaction Date at prices that ranged from $10.65 to $10.67 per share. Upon request, the Reporting Person has agreed to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:16 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 145 | $10.67 | $1,547.15 |
DisclosureSEC source: 0001193125-26-365324 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,851 Read SEC document |
| August 17, 2026 Filed Aug 20, 2026 01:56 UTC | Chicago Atlantic BDC, Inc. LIEN · Entity 6189 | PurchaseCommon Stock | 60,000 | $9.44 | $566,400.00 |
DisclosureSEC source: 0001193125-26-357420 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 F1 · price: The price reported reflects the weighted-average purchase price from several discrete transactions executed throughout the Transaction Date at prices that ranged from $9.39 to $9.44 per share. Upon request, the Reporting Person has agreed to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 21:23 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 25,000 | $10.25 | $256,325.00 |
DisclosureSEC source: 0001213900-26-091788 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,706 F1 · price: The price reported reflects the weighted-average purchase price from several discrete transactions executed throughout the Transaction Date at prices that ranged from $10.17 to $10.29 per share. Upon request, the Reporting Person has agreed to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| April 20, 2026 Filed Apr 23, 2026 01:30 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | GrantCommon Stock | 37,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-046830 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,706 F1 · balance_after: On April 20, 2026, Mr. Mazarakis was awarded 37,099 restricted shares of common stock under the Chicago Atlantic Real Estate Finance, Inc. 2021 Omnibus Incentive Plan. Pursuant to the terms of the award agreement, the 37,099 restricted shares of common stock will vest over a three-year period, with one-third of the restricted stock vesting after 12 months, 24 months and 36 months, respectively. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | Tax withholdingSubordinate Voting Shares | 3,502,150 | $0.67 | $2,346,440.50 |
DisclosureSEC source: 0001104659-25-125208 · tm2534512-2_4seq1.xml · nonDerivative · entry 5 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,833,737 F4 · shares: Certain RSUs held by the reporting person vested on December 17, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 3,502,150 subordinate voting shares were withheld for tax purposes. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | Tax withholdingSubordinate Voting Shares | 801,849 | $0.53 | $424,979.97 |
DisclosureSEC source: 0001104659-25-125208 · tm2534512-2_4seq1.xml · nonDerivative · entry 4 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,335,887 F3 · shares: Certain RSUs held by the reporting person vested on November 13, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 801,849 subordinate voting shares were withheld for tax purposes. Read SEC document |
| December 17, 2025 Filed Dec 30, 2025 21:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | Exercise / conversionRestricted stock units · Derivative | 5,700,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125208 · tm2534512-2_4seq1.xml · derivative · entry 6 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300,000 Underlying: subordinate voting shares · 5,700,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 5,700,000 RSUs on December 17, 2025; 6,650,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date). F2 · derivative.exercise_date: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 5,700,000 RSUs on December 17, 2025; 6,650,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date). F2 · derivative.expiration_date: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 5,700,000 RSUs on December 17, 2025; 6,650,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date). Read SEC document |
| December 17, 2025 Filed Dec 30, 2025 21:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 3,200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-125208 · tm2534512-2_4seq1.xml · nonDerivative · entry 3 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,137,736 F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately. Read SEC document |
| December 17, 2025 Filed Dec 30, 2025 21:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 5,700,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-125208 · tm2534512-2_4seq1.xml · nonDerivative · entry 2 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,937,736 F2 · price: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 5,700,000 RSUs on December 17, 2025; 6,650,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date). Read SEC document |
| November 13, 2025 Filed Dec 30, 2025 21:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 2,037,736 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-125208 · tm2534512-2_4seq1.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,237,736 F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately. Read SEC document |
| October 16, 2025 Filed Oct 16, 2025 21:22 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 8,000 | $12.75 | $102,000.00 |
DisclosureSEC source: 0001193125-25-241563 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,607 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 13:52 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 7,500 | $12.43 | $93,225.00 |
DisclosureSEC source: 0001193125-25-227618 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,607 Read SEC document |
| May 09, 2025 Filed May 13, 2025 11:00 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantRestricted stock units · Derivative | 19,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-047558 · tm2514714-1_4seq1.xml · derivative · entry 2 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000,000 Underlying: subordinate voting shares · 19,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one subordinate voting share. F3 · derivative.exercise_date: The RSUs vest on the following schedule: 1/3 on the day immediately following the date on which the Registrant's 6-month trailing, annualized, adjusted EBITDA exceeds US$150,000,000 and the net leverage of the Company is below 2.2x; 1/3 on the day immediately following the day on which the adjusted EBITDA exceeds US$165,000,000 and the net leverage of the Registrant is below 2.2x; and 1/3 on the day immediately following the date on which the adjusted EBITDA exceeds US$205,000,000 and the net leverage of the Registrant is below 2.2x. F3 · derivative.expiration_date: The RSUs vest on the following schedule: 1/3 on the day immediately following the date on which the Registrant's 6-month trailing, annualized, adjusted EBITDA exceeds US$150,000,000 and the net leverage of the Company is below 2.2x; 1/3 on the day immediately following the day on which the adjusted EBITDA exceeds US$165,000,000 and the net leverage of the Registrant is below 2.2x; and 1/3 on the day immediately following the date on which the adjusted EBITDA exceeds US$205,000,000 and the net leverage of the Registrant is below 2.2x. Read SEC document |
| May 09, 2025 Filed May 13, 2025 11:00 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantRestricted stock units · Derivative | 19,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-047558 · tm2514714-1_4seq1.xml · derivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000,000 Underlying: subordinate voting shares · 19,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one subordinate voting share. F2 · derivative.exercise_date: The RSUs vest on the following schedule: 5,700,000 RSUs on March 6, 2026; 6,650,000 RSUs, at any time on or after March 6, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after March 6, 2028, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date). F2 · derivative.expiration_date: The RSUs vest on the following schedule: 5,700,000 RSUs on March 6, 2026; 6,650,000 RSUs, at any time on or after March 6, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 6,650,000 RSUs, at any time on or after March 6, 2028, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Mazarakis remaining a Service Provider on each such vesting date). Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:10 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | GrantCommon Stock | 28,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-028740 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive COB 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,107 F1 · balance_after: On April 1, 2025, Mr. Mazarakis was awarded 28,398 restricted shares of common stock under the Chicago Atlantic Real Estate Finance, Inc. 2021 Omnibus Incentive Plan. Pursuant to the terms of the award agreement, the 28,398 restricted shares of common stock will vest over a three-year period, with one-third of the restricted stock vesting after 12 months, 24 months and 36 months, respectively. Read SEC document |
| December 17, 2024 Filed Dec 19, 2024 21:47 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 3,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-130226 · tm2431599-4_4seq1.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200,000 F1 · shares: Represents subordinate voting shares granted to Mr. Mazarakis under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, that vest on the grant date. Read SEC document |
| November 08, 2024 Filed Nov 9, 2024 00:25 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 2,779 | $15.82 | $43,963.78 |
DisclosureSEC source: 0001213900-24-096036 · ownership.xml · nonDerivative · entry 2 Mazarakis John · CIK 0001867660 · Director · Executive COB 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,709 F1 · kind: The Reporting Person's sale of Issuer's common stock reported herein was transacted by the Reporting Person's broker as a result of a new margin requirement recently instituted for the account. Upon discovery of such transaction, the Reporting Person acquired an equivalent number of Issuer's shares in the open market. The Reporting Person realized short-swing profits of $105 under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of the sale and subsequent purchase of the Issuer's common shares reported herein. The Reporting Person has voluntarily disgorged to the Issuer all of such short-swing profits realized by the Reporting Person from such transactions. Read SEC document |
| November 07, 2024 Filed Nov 9, 2024 00:25 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | SaleCommon Stock | 2,779 | $15.86 | $44,068.83 |
DisclosureSEC source: 0001213900-24-096036 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive COB 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,930 F1 · kind: The Reporting Person's sale of Issuer's common stock reported herein was transacted by the Reporting Person's broker as a result of a new margin requirement recently instituted for the account. Upon discovery of such transaction, the Reporting Person acquired an equivalent number of Issuer's shares in the open market. The Reporting Person realized short-swing profits of $105 under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of the sale and subsequent purchase of the Issuer's common shares reported herein. The Reporting Person has voluntarily disgorged to the Issuer all of such short-swing profits realized by the Reporting Person from such transactions. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:39 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | GrantCommon Stock | 43,655 | $15.59 | $680,581.45 |
DisclosureSEC source: 0001213900-24-030045 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive COB 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,709 F1 · balance_after: On April 1, 2024, Mr. Mazarakis was awarded 43,655 restricted shares of common stock under the Chicago Atlantic Real Estate Finance, Inc. 2021 Omnibus Incentive Plan. Pursuant to the terms of the award agreement, the 43,655 restricted shares of common stock will vest over a three year period, with one-third of the restricted stock vesting after 12 months, 24 months and 36 months, respectively. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:31 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | GrantCommon Stock | 85,100 | $14.75 | $1,255,225.00 |
DisclosureSEC source: 0001213900-23-045895 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive COB 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,578 F1 · balance_after: On June 1, 2023, Mr. Mazarakis was awarded 85,100 restricted shares of common stock under the Chicago Atlantic Real Estate Finance, Inc. 2021 Omnibus Incentive Plan. Pursuant to the terms of the award agreement, the 85,100 restricted shares of common stock will vest over a three year period, with one-third of the restricted stock vesting after 12 months, 24 months and 36 months, respectively. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 14:40 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 10,000 | $13.19 | $131,900.00 |
DisclosureSEC source: 0001213900-23-020174 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive COB 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,954 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at $13.19 each. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 02:41 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 9,184 | $15.86 | $145,658.24 |
DisclosureSEC source: 0001213900-22-079607 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive COB 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,954 Read SEC document |
| June 03, 2022 Filed Jun 11, 2022 01:36 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | OtherCommon Stock | 61,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-032326 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Executive COB 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,770 F1 · kind: Represents shares distributed by Chicago Atlantic Management, LLC and Chicago Atlantic CRE Manager, LLC, the managing members of Chicago Atlantic Fund QP, LLC and Chicago Atlantic CRE Holdings, LLC, respectively, in connection with the distribution of shares of Chicago Atlantic Real Estate Finance, Inc. held by Chicago Atlantic Fund QP, LLC and Chicago Atlantic CRE Holdings, LLC to their members pursuant to the terms of their respective operating agreements for no consideration. Read SEC document |
| May 23, 2022 Filed May 24, 2022 18:43 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 7,000 | $15.50 | $108,500.00 |
DisclosureSEC source: 0001213900-22-029252 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Exec. Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,250 F1 · price: The price reported is a weighted average price. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each specific price. F2 · balance_after: 156,250 of the shares held directly by Mr. Mazarakis are subject to a 180-day lockup that ends on June 5, 2022. Read SEC document |
| December 08, 2021 Filed Dec 11, 2021 01:50 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 5,000 | $16.00 | $80,000.00 |
DisclosureSEC source: 0001213900-21-064812 · ownership.xml · nonDerivative · entry 2 Mazarakis John · CIK 0001867660 · Director · Exec. Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,000 F4 · balance_after: All of the shares held by Mr. Mazarakis are subject to a 180-day lockup that ends on June 5, 2022. Read SEC document |
| December 07, 2021 Filed Dec 11, 2021 01:50 UTC | Chicago Atlantic Real Estate Finance, Inc. REFI · Entity 6035 | PurchaseCommon Stock | 156,250 | $16.00 | $2,500,000.00 |
DisclosureSEC source: 0001213900-21-064812 · ownership.xml · nonDerivative · entry 1 Mazarakis John · CIK 0001867660 · Director · Exec. Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,250 F1 · balance_after: On December 7, 2021, Mr. Mazarakis purchased 156,250 shares in a private placement offering concurrent with Chicago Atlantic Real Estate Finance, Inc.'s initial public offering. F4 · balance_after: All of the shares held by Mr. Mazarakis are subject to a 180-day lockup that ends on June 5, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.